In epilepsies caused by alterations in mTOR pathway genes, such as DEPDC5, TSC1, or TSC2, the drug rapamycin can be used to manage symptoms as it inhibits mTOR pathway [65,71,72]. This evidence concerns the gene TSC2 and epilepsy.